vs

Side-by-side financial comparison of H2O AMERICA (HTO) and Ultragenyx Pharmaceutical Inc. (RARE). Click either name above to swap in a different company.

Ultragenyx Pharmaceutical Inc. is the larger business by last-quarter revenue ($207.3M vs $199.4M, roughly 1.0× H2O AMERICA). H2O AMERICA runs the higher net margin — 8.1% vs -62.0%, a 70.2% gap on every dollar of revenue. On growth, Ultragenyx Pharmaceutical Inc. posted the faster year-over-year revenue change (25.9% vs 1.5%). Over the past eight quarters, Ultragenyx Pharmaceutical Inc.'s revenue compounded faster (38.0% CAGR vs 15.3%).

H2O Wireless is a United States-based prepaid cell phone service, that utilizes the AT&T network. It is a brand of the mobile virtual network operator (MVNO) Locus Telecommunications, a subsidiary of Telrite Holdings, Inc., since 2019. Locus was formerly a subsidiary of KDDI America corporation, starting in 2010. H2O Wireless is primarily advertised as a non-restrictive phone service for customers to bring or buy unlocked smartphones, although AT&T contract/locked phones may be accepted as well.

Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.

HTO vs RARE — Head-to-Head

Bigger by revenue
RARE
RARE
1.0× larger
RARE
$207.3M
$199.4M
HTO
Growing faster (revenue YoY)
RARE
RARE
+24.4% gap
RARE
25.9%
1.5%
HTO
Higher net margin
HTO
HTO
70.2% more per $
HTO
8.1%
-62.0%
RARE
Faster 2-yr revenue CAGR
RARE
RARE
Annualised
RARE
38.0%
15.3%
HTO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HTO
HTO
RARE
RARE
Revenue
$199.4M
$207.3M
Net Profit
$16.2M
$-128.6M
Gross Margin
Operating Margin
16.6%
-54.7%
Net Margin
8.1%
-62.0%
Revenue YoY
1.5%
25.9%
Net Profit YoY
-29.2%
3.5%
EPS (diluted)
$0.45
$-1.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTO
HTO
RARE
RARE
Q4 25
$199.4M
$207.3M
Q3 25
$243.5M
$159.9M
Q2 25
$197.8M
$166.5M
Q1 25
$164.9M
$139.3M
Q4 24
$196.5M
$164.6M
Q3 24
$216.7M
$139.5M
Q2 24
$173.1M
$147.0M
Q1 24
$150.0M
$108.8M
Net Profit
HTO
HTO
RARE
RARE
Q4 25
$16.2M
$-128.6M
Q3 25
$45.1M
$-180.4M
Q2 25
$24.7M
$-115.0M
Q1 25
$16.6M
$-151.1M
Q4 24
$22.9M
$-133.2M
Q3 24
$38.7M
$-133.5M
Q2 24
$20.7M
$-131.6M
Q1 24
$11.7M
$-170.7M
Operating Margin
HTO
HTO
RARE
RARE
Q4 25
16.6%
-54.7%
Q3 25
26.5%
-106.9%
Q2 25
22.2%
-64.8%
Q1 25
21.8%
-102.6%
Q4 24
22.2%
-74.3%
Q3 24
26.9%
-94.6%
Q2 24
23.4%
-79.1%
Q1 24
18.6%
-151.9%
Net Margin
HTO
HTO
RARE
RARE
Q4 25
8.1%
-62.0%
Q3 25
18.5%
-112.8%
Q2 25
12.5%
-69.0%
Q1 25
10.0%
-108.5%
Q4 24
11.7%
-80.9%
Q3 24
17.8%
-95.7%
Q2 24
12.0%
-89.5%
Q1 24
7.8%
-156.8%
EPS (diluted)
HTO
HTO
RARE
RARE
Q4 25
$0.45
$-1.28
Q3 25
$1.27
$-1.81
Q2 25
$0.71
$-1.17
Q1 25
$0.49
$-1.57
Q4 24
$0.70
$-1.34
Q3 24
$1.17
$-1.40
Q2 24
$0.64
$-1.52
Q1 24
$0.36
$-2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTO
HTO
RARE
RARE
Cash + ST InvestmentsLiquidity on hand
$20.7M
$421.0M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$1.5B
$-80.0M
Total Assets
$5.1B
$1.5B
Debt / EquityLower = less leverage
1.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTO
HTO
RARE
RARE
Q4 25
$20.7M
$421.0M
Q3 25
$11.3M
$202.5M
Q2 25
$19.8M
$176.3M
Q1 25
$23.7M
$127.1M
Q4 24
$11.1M
$174.0M
Q3 24
$4.0M
$150.6M
Q2 24
$22.8M
$480.7M
Q1 24
$4.5M
$112.3M
Total Debt
HTO
HTO
RARE
RARE
Q4 25
$1.9B
Q3 25
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HTO
HTO
RARE
RARE
Q4 25
$1.5B
$-80.0M
Q3 25
$1.5B
$9.2M
Q2 25
$1.5B
$151.3M
Q1 25
$1.4B
$144.2M
Q4 24
$1.4B
$255.0M
Q3 24
$1.3B
$346.8M
Q2 24
$1.3B
$432.4M
Q1 24
$1.2B
$140.3M
Total Assets
HTO
HTO
RARE
RARE
Q4 25
$5.1B
$1.5B
Q3 25
$5.0B
$1.2B
Q2 25
$4.8B
$1.3B
Q1 25
$4.7B
$1.3B
Q4 24
$4.7B
$1.5B
Q3 24
$4.6B
$1.5B
Q2 24
$4.4B
$1.6B
Q1 24
$4.4B
$1.3B
Debt / Equity
HTO
HTO
RARE
RARE
Q4 25
1.23×
Q3 25
Q2 25
Q1 25
Q4 24
1.26×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTO
HTO
RARE
RARE
Operating Cash FlowLast quarter
$63.5M
$-99.8M
Free Cash FlowOCF − Capex
$-100.8M
FCF MarginFCF / Revenue
-48.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
3.92×
TTM Free Cash FlowTrailing 4 quarters
$-472.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTO
HTO
RARE
RARE
Q4 25
$63.5M
$-99.8M
Q3 25
$77.3M
$-91.4M
Q2 25
$60.8M
$-108.3M
Q1 25
$43.2M
$-166.5M
Q4 24
$41.5M
$-79.3M
Q3 24
$53.5M
$-67.0M
Q2 24
$49.3M
$-77.0M
Q1 24
$51.2M
$-190.7M
Free Cash Flow
HTO
HTO
RARE
RARE
Q4 25
$-100.8M
Q3 25
$-92.7M
Q2 25
$-110.7M
Q1 25
$-167.8M
Q4 24
$-79.5M
Q3 24
$-68.6M
Q2 24
$-79.0M
Q1 24
$-193.9M
FCF Margin
HTO
HTO
RARE
RARE
Q4 25
-48.6%
Q3 25
-58.0%
Q2 25
-66.5%
Q1 25
-120.5%
Q4 24
-48.3%
Q3 24
-49.2%
Q2 24
-53.7%
Q1 24
-178.2%
Capex Intensity
HTO
HTO
RARE
RARE
Q4 25
0.5%
Q3 25
0.8%
Q2 25
1.5%
Q1 25
1.0%
Q4 24
0.1%
Q3 24
1.2%
Q2 24
1.4%
Q1 24
3.0%
Cash Conversion
HTO
HTO
RARE
RARE
Q4 25
3.92×
Q3 25
1.71×
Q2 25
2.47×
Q1 25
2.61×
Q4 24
1.81×
Q3 24
1.39×
Q2 24
2.38×
Q1 24
4.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HTO
HTO

Water Utility Services$191.0M96%
Other$8.4M4%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

Related Comparisons